Side-by-side financials for ACHV and NTLA. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACHV | NTLA |
|---|---|---|
| Market cap | - | $1.70 B |
| US-listed rank | - | #2239 |
| Revenue (latest FY) | $0.00 | $67.67M |
| Net income (latest FY) | -$54.65M | -$412.69M |
| Net margin | - | -609.9% |
| SEC filings | 999 | 687 |
Full pages: ACHIEVE LIFE SCIENCES, INC. and Intellia Therapeutics, Inc., or browse the full rankings.